Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.
Press releases published on September 3, 2025
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting
GlobeNewswire
·
September 3, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Longeveron® Announces Key Leadership Updates
GlobeNewswire
·
September 3, 2025
Than Powell, Chief Business Officer and head of business development, appointed Interim CEO Dr. Joshua Hare, co-founder and chief science officer, appointed Executive Chairman of the Board of Directors Wa’el Hashad to step down as CEO and Board member …
SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes
GlobeNewswire
·
September 3, 2025
MIAMI, Sept. 03, 2025 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing a multi-specific human anti-thymocyte …
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 3, 2025
SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 3, 2025
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …
American Botanical Council Debuts Saw Palmetto Educational Video on HerbTV
GlobeNewswire
·
September 3, 2025
Austin, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The nonprofit American Botanical Council (ABC) announces the premiere of its new educational video, “Saw Palmetto: Safe and Effective Herb for Prostate and Men’s Urinary Health.” The video is available on …
Clover Health CEO Andrew Toy Testifies Before Congress on the Transformative Role of AI in Healthcare, Highlights how Clover is Leading the Way
GlobeNewswire
·
September 3, 2025
WASHINGTON, D.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) – Clover Health CEO Andrew Toy today had the honor to deliver testimony before the U.S. House of …
HBox Names Dr. Rahul Chaudhary Chief Medical Officer To Drive Innovation At the Intersection of Clinical Care and AI
EIN Presswire
·
September 3, 2025
DETROIT, MI, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- HBox today announced the appointment of Dr. Rahul Chaudhary, MD, as its new Chief Medical Officer (CMO), marking the culmination of a six-month search for a leader who embodies the …
Banner Health honored for commitment to well-being of physicians
GlobeNewswire
·
September 3, 2025
PHOENIX, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Banner Health has again earned prestigious recognition from American Medical Association (AMA) for the continued commitment to reducing burnout and promoting well-being among health care workers. This marks the …
New Study: Gut Health Program Cuts Infant Eczema Odds by 83% in C-Section Babies
GlobeNewswire
·
September 3, 2025
AUSTIN, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- A new study found that babies born by C-section had 83% lower odds of developing eczema when their families participated in a 6-month gut health support program, compared to those who didn't receive the …
PharmaCorp to Acquire Two Pharmacies in Western Canada
GlobeNewswire
·
September 3, 2025
SASKATOON, Saskatchewan, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has entered into definitive share purchase agreements, each dated August 29, 2025 (the “ …
Microbix Hosts Ontario Minister Stephen Crawford
GlobeNewswire
·
September 3, 2025
MISSISSAUGA, Ontario, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces its hosting of the Honourable Stephen Crawford, Ontario’s Minister of …
Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
GlobeNewswire
·
September 3, 2025
First-ever potentially disease-modifying therapy for uncontrolled Graves’ disease patients Of 21 patients who entered the six-month off-treatment follow-up period, ~80% (17/21) demonstrated response, resulting in normal thyroid function (T3 and T4 less …
PDE4B Inhibitor Market Poised for Strong Growth by 2034 | DelveInsight
GlobeNewswire
·
September 3, 2025
New York, USA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PDE4B Inhibitor Market Poised for Strong Growth by 2034 | DelveInsight The outlook for the PDE4B inhibitors market is changing as this drug class demonstrates significant therapeutic promise in respiratory …
Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
GlobeNewswire
·
September 3, 2025
First-ever potentially disease-modifying therapy for uncontrolled Graves’ disease patients Of 21 patients who entered the six-month off-treatment follow-up period, ~80% (17/21) demonstrated response, resulting in normal thyroid function (T3 and T4 less …
AlphaTON Capital Corp Launches TON Digital Asset Treasury Strategy for the Telegram Ecosystem
GlobeNewswire
·
September 3, 2025
AlphaTON Capital Unlocks Public Market Access to Toncoin (TON) and Telegram’s Billion-User Ecosystem Brittany Kaiser, pioneer in data protection, digital assets, and the public equity markets appointed Chief Executive Officer and Board Member Formerly …
Society for Science Recognizes Top 300 Middle School Innovators in Nation’s Premier STEM Competition
GlobeNewswire
·
September 3, 2025
WASHINGTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Society for Science is proud to announce the Top 300 Junior Innovators in the 2025 Thermo Fisher Scientific Junior Innovators Challenge (Thermo Fisher JIC)—the nation’s premier science, technology, engineering …
Arcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Cream 0.3% to Expand Indication for Treatment of Plaque Psoriasis in Children Ages 2 to 5
GlobeNewswire
·
September 3, 2025
If approved, ZORYVE cream would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in children as young as 2, offering patients and caregivers an important alternative to topical steroids and vitamin-D analogs ZORYVE cream is …
Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS Results
GlobeNewswire
·
September 3, 2025
SOLANA BEACH, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic …
Clinical Asset Management leader TRIMEDX adds to leadership team with key technology hire to accelerate innovation and AI strategy
GlobeNewswire
·
September 3, 2025
Indianapolis, Indiana, Sept. 03, 2025 (GLOBE NEWSWIRE) -- TRIMEDX—an industry-leading, independent clinical asset management company delivering comprehensive clinical engineering services, clinical asset informatics, and medical device cybersecurity—has …